Thousand Oaks biotech giant Amgen details plans for cash

You are here: Home > Central Coast Health Watch > Current Article

Thousand Oaks biotech giant Amgen details plans for cash

By Marissa Nall / Friday, April 27th, 2018 / Comments Off on Thousand Oaks biotech giant Amgen details plans for cash

Proposals to streamline regulatory approval of new drugs would bode well for biotech companies like Amgen in Thousand Oaks. New products and sales outside the U.S. drove up earnings for Amgen as the world’s biggest biotech company looks ahead to upcoming launches and continues to look for ways to deploy its cash. Increasingly, that cash…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.